Lamotrigine Kit
Product Images NDC 69102-137

9 FDA label images from Owp Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Lamotrigine (NDC 69102-137). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Owp Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structureowp (Structure Owp)

Structureowp (Structure Owp)
Chemical structure of lamotrigine showing its molecular arrangement with chlorine atoms, amine groups, and a triazine ring.*
FDA Label Image

Graph1 (Figure 1)

Graph1 (Figure 1)
A Kaplan-Meier failure probability plot comparing Lamotrigine and placebo over time in weeks. The Y-axis indicates failure probability (%) from 0 to 100%, and the X-axis shows weeks from 0 to 100. Two curves are labeled: one for Lamotrigine and one for Placebo, with censored data points marked along the curves.*
FDA Label Image

Graph2 (Figure 2)

Graph2 (Figure 2)
A Kaplan-Meier plot depicting failure probability (%) over weeks for Lamotrigine Kit 25 mg compared to placebo. The graph shows two survival curves, with failure probability on the y-axis and weeks on the x-axis, including censoring marks. Lamotrigine demonstrates a lower failure probability over time compared to placebo.*
FDA Label Image

Torrentlogo (Logo Pi Owp)

FDA Label Image

Shape (Tabletimage Owp)

Shape (Tabletimage Owp)
Tablet dimensional drawing of Lamotrigine showing upper and lower face designs. The 25 mg tablet has "45" embossed on the upper face and a scored line on the lower face, while the 100 mg tablet features "1047" on the upper face and a scored line on the lower face.*
FDA Label Image

Torrentlogo-2 (Logo mg Owp)

FDA Label Image

Bluekit (Starterkit Blue)

Bluekit (Starterkit Blue)
Packaging label for Lamotrigine Kit containing 25 mg tablets. The label indicates a Blue Starter Kit with 35 tablets, manufactured by OWP Pharmaceuticals, Inc. The labeling includes dosage instructions for weeks 1 through 5, storage information, and a barcode. The package design features a blue and white color scheme with wave graphics and the text "Lamotrigine Tablets, USP" prominently displayed.*
FDA Label Image

Greenkit (Starterkit Green)

Greenkit (Starterkit Green)
Lamotrigine Kit packaging label for tablets, USP by OWP Pharmaceuticals, Inc. The kit includes 25 mg and 100 mg lamotrigine tablets. The label details dosage instructions for weeks 1-5, with weeks 1-2 and 3-4 using 25 mg tablets and week 5 using 100 mg tablets. Packaging includes storage instructions and a barcode.*
FDA Label Image

Orangekit (Starterkit Orange)

Orangekit (Starterkit Orange)
Packaging label for LAMOTRIGINE Kit, containing Lamotrigine Tablets USP in an Orange Starter Kit. The kit includes 42 tablets of 25 mg and 7 tablets of 100 mg strength. The label indicates instructions for dosing over weeks 1 to 5 and is manufactured by OWP Pharmaceuticals, Inc. The design features orange wave graphics and dose instructions on the front and sides.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.